You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aldehyde Dehydrogenase

Showing 1 - 25 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease Trial in Houston (Stem Cell Therapy, Control (plasma))

Active, not recruiting
Has Results
  • Coronary Artery Disease
  • Stem Cell Therapy
  • Control (plasma)
  • Houston, Texas
    Texas Heart Institute/Baylor St. Luke's Medical Center
Apr 25, 2022

Fatigue, Gastrointestinal Cancer, Aldehyde Dehydrogenase Trial in Seoul (ALDH enzyme supplementation)

Recruiting
  • Fatigue
  • +2 more
  • ALDH enzyme supplementation
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Dec 24, 2021

Flushing, Alcohol-Related Disorders, Aldehyde Dehydrogenase Deficiency Trial in San Francisco (Brimonidine Tartrate, Placebo

Completed
  • Flushing
  • +2 more
  • Brimonidine Tartrate
  • Placebo Vehicle Gel
  • San Francisco, California
    UC, San Francisco
Apr 30, 2020

Sjogren-Larsson Syndrome Trial in Omaha (ADX-629)

Recruiting
  • Sjogren-Larsson Syndrome
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 7, 2022

No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)

Not yet recruiting
  • No-Reflow Phenomenon
  • Alpha Lipoic Acid plus the standard care for post-PCI MI
  • The standard care for post-PCI MI
  • (no location specified)
Apr 29, 2022

Endothelial Function and Regenerative Cell Exhaustion

Not yet recruiting
  • Diabetes Mellitus, Type 2
    • Scarborough, Ontario, Canada
      Diagnostic Assessment Centre
    Oct 25, 2023

    Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule

    Recruiting
    • Cardiovascular Diseases
    • +3 more
    • Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
    • North York, Ontario, Canada
    • +3 more
    Nov 7, 2022

    Pro-vascular Regenerative Cell Exhaustion in Polycystic Ovarian

    Not yet recruiting
    • Polycystic Ovary Syndrome
      • Newmarket, Ontario, Canada
      • +2 more
      Jun 6, 2022

      Sjögren-Larsson Syndrome Trial in Omaha, Hershey, Fairfax (Active topical NS2 1% dermatologic cream, Vehicle 0.0% NS2

      Completed
      Has Results
      • Sjögren-Larsson Syndrome
      • Active topical NS2 1% dermatologic cream
      • Vehicle placebo 0.0% NS2 dermatologic cream
      • Omaha, Nebraska
      • +2 more
      Nov 16, 2022

      South Asian vs European Origins on Circulating Regenerative Cell

      Recruiting
      • Diabetes
      • +6 more
        • Markham, Ontario, Canada
        • +2 more
        Feb 12, 2022

        Alcohol Use Disorder Trial in Los Angeles (ANS-6637 Low Dose, ANS-6637 High Dose, Matched Placebo)

        Withdrawn
        • Alcohol Use Disorder
        • ANS-6637 Low Dose
        • +2 more
        • Los Angeles, California
          UCLA Addictions Lab
        May 20, 2021

        Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

        Active, not recruiting
        • Mucinous Adenocarcinoma of the Rectum
        • +7 more
        • bevacizumab
        • +4 more
        • Los Angeles, California
          USC Norris Comprehensive Cancer Center
        Aug 5, 2022

        Relapse in Patients Harboring Adenocarcinoma and Squamous Cell

        Completed
        • Lung Cancer, Nonsmall Cell
        • +2 more
        • Exposure to lung cancer stem cells
        • Modena, Italy
          Azienda Ospedaliero-Universitaria di Modena
        May 27, 2021

        Atherosclerosis, Cardiovascular Diseases, Diabetes, Type 2 Trial in North York, Scarborough (Semaglutide Pen Injector)

        Recruiting
        • Atherosclerosis
        • +3 more
        • Semaglutide Pen Injector
        • North York, Ontario, Canada
        • +1 more
        May 12, 2023

        Molybdenum Cofactor Deficiency, Type A Trial in Worldwide (ORGN001 (formerly ALXN1101))

        Completed
        • Molybdenum Cofactor Deficiency, Type A
        • ORGN001 (formerly ALXN1101)
        • Milwaukee, Wisconsin
        • +5 more
        Oct 13, 2022

        Surgical Recovery, Pain, Postoperative Trial in Stanford (N-acetyl cysteine, Normal Saline)

        Enrolling by invitation
        • Surgical Recovery
        • Pain, Postoperative
        • N-acetyl cysteine
        • Normal Saline
        • Stanford, California
          Stanford University School of Medicine
        Dec 7, 2022

        Molybdenum Cofactor Deficiency (MoCD), Rare Autosomal Recessive Disorder, Deficiency of Activity of Molybdenum-dependent Enzymes

        Completed
        • Molybdenum Cofactor Deficiency (MoCD)
        • +2 more
        • Baltimore, Maryland
          Parexel Baltimore EPCU
        Mar 15, 2019

        Predict Acute Respiratory Distress Syndrome(ARDS) in Sepsis

        Recruiting
        • Sepsis
        • ALDH2 rs671 mutation
        • Jinan, China
          Qilu Hospital of Shandong University
        Jun 13, 2023

        Healthy Trial in Los Angeles (Phenotype Feedback Intervention, Genotype Feedback Intervention)

        Active, not recruiting
        • Healthy
        • Phenotype Feedback Intervention
        • Genotype Feedback Intervention
        • Los Angeles, California
          University of Southern California
        Apr 14, 2022

        Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))

        Not yet recruiting
        • Relapsed Sarcomas
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        Apr 18, 2022

        Alcoholic Hepatitis Trial in New Delhi (Saturated Fat- Desi Ghee (Clarified Butter), Soyabean Oil)

        Completed
        • Alcoholic Hepatitis
        • Saturated Fat- Desi Ghee (Clarified Butter)
        • Soyabean Oil
        • New Delhi, Delhi, India
          Institute of Liver and Biliary Sciences
        Mar 29, 2022

        Peripheral Arterial Occlusive Disease Trial in Ryazan (drug, device, other)

        Recruiting
        • Peripheral Arterial Occlusive Disease
        • Ryazan, Russian Federation
          RyazanSMU
        Jun 27, 2023

        Peripheral Artery Occlusive Disease, Acute Coronary Syndrome Trial in Tainan (Observational research)

        Recruiting
        • Peripheral Artery Occlusive Disease
        • Acute Coronary Syndrome
        • Observational research
        • Tainan, Taiwan
          Wei-Ting Chang
        Oct 1, 2021

        Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image

        Recruiting
        • Adult Gliomas, Mixed
        • Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
        • Magnetic Resonance Image (MRI)
        • San Francisco, California
          University of California, San Francisco
        May 9, 2023

        Smoking Cessation Trial (nicotine polacrilex, nicotine transdermal system, nicotine inhaler)

        Terminated
        Has Results
        • Smoking Cessation
        • nicotine polacrilex
        • +2 more
        • (no location specified)
        Jan 13, 2023